JPRN-UMIN000029799已完成未知
Blood pharmacokinetic comparative study of Kampo preparations (Kakkonto) in Japanese healthy male volunteers (kakkonto decoction and its extract fine granule product ) - Blood pharmacokinetic comparative study of Kampo preparations (Kakkonto) in Japanese healthy male volunteers (kakkonto decoction and its extract fine granule product )
ational Institute of Health Sciences Division of Pharmacognosy, Phytochemistry and Narcotics0 个研究点目标入组 40 人开始时间: 2017年11月6日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 40years-old（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •1.Subjects with a disease under treatment 2.Subjects who are sensitive to drugs or have idiosyncrasy or the history of idiosyncrasy 3.Subjects with allergy disease such as bronchial asthma, pollenosis, atopic dermatitis etc. 4.Subjects who have diseases of heart, liver, kidney, digestive organs, respiratory organs and blood function or the history of the diseases or the severe operation history of the diseases and are judged as ineligible to participate in the study by the principal (or sub) doctor (excluding extirpation of appendicitis) 5.Subjects with remarkably weak stomach 6.Subjects with anorexia, nausea, vomiting 7.Subjects with tendency of remarkable sweating 8.Subjects with severe hypertension 9.Subjects with dysuria 10.Subjects with hyperthyroidism 11.Subjects with positive reaction in immunological serum testing or urine abuse test 12.Subjects who cannot keep no smoking in hospital and temperance from 2 days before hospitalization to leaving hospital 13.Subjects who used other drugs or took others drugs within one week before administration of the study drug or need to use other drugs or take other drugs in the first period 14.Subjects who participated in other clinical trials and received medication within 12 weeks before administration of the study drug in the first period 15.Subjects who donated 400 mL or 200 mL of blood within 12 or 4 weeks before administration of the study drug or have the schedule of donation of blood component (plasma or platelet) or donated the component within 2 weeks before administration of the study drug in the first period 16.Subjects who are judged as ineligible to participate in the study for other reasons by the principal (or sub) doctor
研究者
相似试验
已完成
不适用
Blood pharmacokinetic comparative study of Kampo preparations (Kakkonto) in japanese healthy male volunteers (kakkonto tablet and its extract granule)Healty male adultJPRN-UMIN000030188ational Institute of Health Sciences Division of Pharmacognosy, Phytochemistry and Narcotics20
尚未招募
2 期
Herbal oil and Cream for the treatment of AcneCTRI/2020/10/028499niversity College of Ayurved DSRRA
尚未招募
不适用
Role of kankarishta in the management of EczemaCTRI/2020/10/028185shubhdeep ayurved medical college indore
已完成
不适用
Blood pharmacokinetic study on fine-granulated of Kracie hachimijiogan ryo extract in humansJPRN-UMIN000009334Polyene Project , Ltd6
已完成
不适用
Comparative clinical study of kokilaksha kshara and Ghana in the management of UrolithiasisCTRI/2022/03/040713Government Ayurved Hospital Vadodara36